Chargement en cours...
Strengths and Challenges of Secretory Ribonucleases as AntiTumor Agents
Approaches to develop effective drugs to kill cancer cells are mainly focused either on the improvement of the currently used chemotherapeutics or on the development of targeted therapies aimed at the selective destruction of cancer cells by steering specific molecules and/or enhancing the immune re...
Enregistré dans:
| Publié dans: | Pharmaceutics |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7828032/ https://ncbi.nlm.nih.gov/pubmed/33435285 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13010082 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|